{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:53:56Z","timestamp":1788386036113,"version":"build-2803163510"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["AU-0042-2003061"],"award-info":[{"award-number":["AU-0042-2003061"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IgM Biosciences"},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI173348"],"award-info":[{"award-number":["U01-AI173348"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UH2-AI171611"],"award-info":[{"award-number":["UH2-AI171611"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-59294-0","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T16:05:51Z","timestamp":1745942751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4009-6823","authenticated-orcid":false,"given":"Ashwin Kumar","family":"Ramesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jwala Priyadarsini","family":"Sivaccumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luona","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1304-8161","authenticated-orcid":false,"given":"Chen-Ni","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Shiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Strohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3935-4637","authenticated-orcid":false,"given":"Tongqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4348-2180","authenticated-orcid":false,"given":"Ningyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5412-6942","authenticated-orcid":false,"given":"Kai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-1561","authenticated-orcid":false,"given":"Xinli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1420-2271","authenticated-orcid":false,"given":"Tong-Ming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-2335","authenticated-orcid":false,"given":"Zhiqiang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"59294_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3181-y","volume":"18","author":"S Caini","year":"2018","unstructured":"Caini, S. et al. Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014. BMC Infect. Dis. 18, 269 (2018).","journal-title":"BMC Infect. Dis."},{"key":"59294_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jinf.2013.11.013","volume":"68","author":"D Cromer","year":"2014","unstructured":"Cromer, D. et al. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J. Infect. 68, 363\u2013371 (2014).","journal-title":"J. Infect."},{"key":"59294_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","volume":"22","author":"Y Wu","year":"2014","unstructured":"Wu, Y., Wu, Y., Tefsen, B., Shi, Y. & Gao, G. F. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol. 22, 183\u2013191 (2014).","journal-title":"Trends Microbiol."},{"key":"59294_CR4","doi-asserted-by":"publisher","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","volume":"9","author":"S Tong","year":"2013","unstructured":"Tong, S. et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 9, e1003657 (2013).","journal-title":"PLoS Pathog."},{"key":"59294_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","volume":"10","author":"JL McAuley","year":"2019","unstructured":"McAuley, J. L., Gilbertson, B. P., Trifkovic, S., Brown, L. E. & McKimm-Breschkin, J. L. Influenza virus neuraminidase structure and functions. Front. Microbiol. 10, 39 (2019).","journal-title":"Front. Microbiol."},{"key":"59294_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2183\/pjab.88.226","volume":"88","author":"N Sriwilaijaroen","year":"2012","unstructured":"Sriwilaijaroen, N. & Suzuki, Y. Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 88, 226\u2013249 (2012).","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"59294_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0042-6822(89)90249-3","volume":"173","author":"GN Rogers","year":"1989","unstructured":"Rogers, G. N. & D\u2019Souza, B. L. Receptor binding properties of human and animal H1 influenza virus isolates. Virology 173, 317\u2013322 (1989).","journal-title":"Virology"},{"key":"59294_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0042-6822(83)90150-2","volume":"127","author":"GN Rogers","year":"1983","unstructured":"Rogers, G. N. & Paulson, J. C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127, 361\u2013373 (1983).","journal-title":"Virology"},{"key":"59294_CR9","doi-asserted-by":"publisher","unstructured":"Pauly, M. D., Procario, M. C. & Lauring, A. S. A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses. Elife 6, https:\/\/doi.org\/10.7554\/eLife.26437 (2017).","DOI":"10.7554\/eLife.26437"},{"key":"59294_CR10","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1128\/JVI.80.7.3675-3678.2006","volume":"80","author":"E Nobusawa","year":"2006","unstructured":"Nobusawa, E. & Sato, K. Comparison of the mutation rates of human influenza A and B viruses. J. Virol. 80, 3675\u20133678 (2006).","journal-title":"J. Virol."},{"key":"59294_CR11","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1099\/vir.0.83184-0","volume":"88","author":"NJ McDonald","year":"2007","unstructured":"McDonald, N. J., Smith, C. B. & Cox, N. J. Antigenic drift in the evolution of H1N1 influenza A viruses resulting from deletion of a single amino acid in the haemagglutinin gene. J. Gen. Virol. 88, 3209\u20133213 (2007).","journal-title":"J. Gen. Virol."},{"key":"59294_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.antiviral.2013.03.021","volume":"98","author":"NS Laursen","year":"2013","unstructured":"Laursen, N. S. & Wilson, I. A. Broadly neutralizing antibodies against influenza viruses. Antivir. Res. 98, 476\u2013483 (2013).","journal-title":"Antivir. Res."},{"key":"59294_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41586-021-04356-8","volume":"602","author":"JJ Guthmiller","year":"2022","unstructured":"Guthmiller, J. J. et al. Broadly neutralizing antibodies target a haemagglutinin anchor epitope. Nature 602, 314\u2013320 (2022).","journal-title":"Nature"},{"key":"59294_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.coviro.2012.02.005","volume":"2","author":"DC Ekiert","year":"2012","unstructured":"Ekiert, D. C. & Wilson, I. A. Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr. Opin. Virol. 2, 134\u2013141 (2012).","journal-title":"Curr. Opin. Virol."},{"key":"59294_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105785","volume":"221","author":"X Sun","year":"2024","unstructured":"Sun, X. et al. Broadly neutralizing antibodies to combat influenza virus infection. Antivir. Res. 221, 105785 (2024).","journal-title":"Antivir. Res."},{"key":"59294_CR16","doi-asserted-by":"publisher","unstructured":"Biswas, M., Yamazaki, T., Chiba, J. & Akashi-Takamura, S. Broadly neutralizing antibodies for influenza: passive immunotherapy and intranasal vaccination. Vaccines 8, https:\/\/doi.org\/10.3390\/vaccines8030424 (2020).","DOI":"10.3390\/vaccines8030424"},{"key":"59294_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1086297","volume":"14","author":"C Jiao","year":"2023","unstructured":"Jiao, C., Wang, B., Chen, P., Jiang, Y. & Liu, J. Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses. Front Immunol. 14, 1086297 (2023).","journal-title":"Front Immunol."},{"key":"59294_CR18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/ni.3684","volume":"18","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer, R. et al. Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins. Nat. Immunol. 18, 464\u2013473 (2017).","journal-title":"Nat. Immunol."},{"key":"59294_CR19","doi-asserted-by":"publisher","first-page":"e9106","DOI":"10.1371\/journal.pone.0009106","volume":"5","author":"RH Friesen","year":"2010","unstructured":"Friesen, R. H. et al. New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets. PLoS ONE 5, e9106 (2010).","journal-title":"PLoS ONE"},{"key":"59294_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.chom.2014.04.009","volume":"15","author":"K Tharakaraman","year":"2014","unstructured":"Tharakaraman, K., Subramanian, V., Cain, D., Sasisekharan, V. & Sasisekharan, R. Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure. Cell Host Microbe 15, 644\u2013651 (2014).","journal-title":"Cell Host Microbe"},{"key":"59294_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41586-021-03673-2","volume":"595","author":"Z Ku","year":"2021","unstructured":"Ku, Z. et al. Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature 595, 718\u2013723 (2021).","journal-title":"Nature"},{"key":"59294_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/440435a","volume":"440","author":"K Shinya","year":"2006","unstructured":"Shinya, K. et al. Influenza virus receptors in the human airway. Nature 440, 435\u2013436 (2006).","journal-title":"Nature"},{"key":"59294_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0168-1702(93)90056-S","volume":"29","author":"JNSS Couceiro","year":"1993","unstructured":"Couceiro, J. N. S. S., Paulson, J. C. & Baum, L. G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29, 155\u2013165 (1993).","journal-title":"Virus Res."},{"key":"59294_CR24","doi-asserted-by":"crossref","unstructured":"Gerhard, W., Yewdell, J., Frankel, M. E. & Webster, R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290, 713\u2013717 (1981).","DOI":"10.1038\/290713a0"},{"key":"59294_CR25","doi-asserted-by":"crossref","unstructured":"Caton, A. J., Brownlee, G. G., Yewdell, J. W. & Gerhard, W. The antigenic structure of the influenza virus A\/PR\/8\/34 hemagglutinin (H1 subtype). Cell 31, 417\u2013427 (1982).","DOI":"10.1016\/0092-8674(82)90135-0"},{"key":"59294_CR26","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1126\/science.1093155","volume":"303","author":"SJ Gamblin","year":"2004","unstructured":"Gamblin, S. J. et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303, 1838\u20131842 (2004).","journal-title":"Science"},{"key":"59294_CR27","doi-asserted-by":"crossref","unstructured":"Wiley, D. C., Wilson, I. A. & Skehel, J. J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373\u2013378 (1981).","DOI":"10.1038\/289373a0"},{"key":"59294_CR28","doi-asserted-by":"crossref","unstructured":"Wilson, I. A., Skehel, J. J. & Wiley, D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289 366\u2013373 (1981).","DOI":"10.1038\/289366a0"},{"key":"59294_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2217\/imt.11.167","volume":"4","author":"J Ye","year":"2012","unstructured":"Ye, J., Shao, H. & Perez, D. R. Passive immune neutralization strategies for prevention and control of influenza A infections. Immunotherapy 4, 175\u2013186 (2012).","journal-title":"Immunotherapy"},{"key":"59294_CR30","doi-asserted-by":"crossref","unstructured":"Vareckov\u00e1, E., Mucha, V., Wharton, S. A. & Kostolansk\u00fd, F. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies. Arch Virol. 148, 469\u2013486 (2003).","DOI":"10.1007\/s00705-002-0932-1"},{"key":"59294_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2022.101207","volume":"53","author":"X Sun","year":"2022","unstructured":"Sun, X., Ling, Z., Yang, Z. & Sun, B. Broad neutralizing antibody-based strategies to tackle influenza. Curr. Opin. Virol. 53, 101207 (2022).","journal-title":"Curr. Opin. Virol."},{"key":"59294_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33529-w","volume":"13","author":"SM Ghafoori","year":"2023","unstructured":"Ghafoori, S. M. et al. Structural characterisation of hemagglutinin from seven Influenza A H1N1 strains reveal diversity in the C05 antibody recognition site. Sci. Rep. 13, 6940 (2023).","journal-title":"Sci. Rep."},{"key":"59294_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37122-z","volume":"13","author":"NJ Swanson","year":"2023","unstructured":"Swanson, N. J. et al. 2019-2020 H1N1 clade A5a.1 viruses have better in vitro fitness compared with the co-circulating A5a.2 clade. Sci. Rep. 13, 10223 (2023).","journal-title":"Sci. Rep."},{"key":"59294_CR34","doi-asserted-by":"publisher","first-page":"e1005856","DOI":"10.1371\/journal.ppat.1005856","volume":"12","author":"E Visher","year":"2016","unstructured":"Visher, E., Whitefield, S. E., McCrone, J. T., Fitzsimmons, W. & Lauring, A. S. The mutational robustness of influenza A Virus. PLOS Pathog. 12, e1005856 (2016).","journal-title":"PLOS Pathog."},{"key":"59294_CR35","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura, K., Stecher, G. & Kumar, S. MEGA11: molecular evolutionary genetics analysis version 11. Mol. Biol. Evol. 38, 3022\u20133027 (2021).","journal-title":"Mol. Biol. Evol."},{"key":"59294_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21954-2","volume":"12","author":"A Creanga","year":"2021","unstructured":"Creanga, A. et al. A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies. Nat. Commun. 12, 1722 (2021).","journal-title":"Nat. Commun."},{"key":"59294_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."},{"key":"59294_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"59294_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"59294_CR40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1128\/CVI.00613-15","volume":"23","author":"M Zacour","year":"2016","unstructured":"Zacour, M. et al. Standardization of hemagglutination inhibition assay for influenza serology allows for high reproducibility between laboratories. Clin. Vaccin. Immunol. 23, 236\u2013242 (2016).","journal-title":"Clin. Vaccin. Immunol."},{"key":"59294_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1586\/erv.13.35","volume":"12","author":"A Reber","year":"2013","unstructured":"Reber, A. & Katz, J. Immunological assessment of influenza vaccines and immune correlates of protection. Expert Rev. Vaccines 12, 519\u2013536 (2013).","journal-title":"Expert Rev. Vaccines"},{"key":"59294_CR42","doi-asserted-by":"publisher","unstructured":"Chen, Y. Q., Lan, L. Y., Huang, M., Henry, C. & Wilson, P. C. Hemagglutinin stalk-reactive antibodies interfere with influenza virus neuraminidase activity by steric hindrance. J. Virol. 93, https:\/\/doi.org\/10.1128\/JVI.01526-18 (2019).","DOI":"10.1128\/JVI.01526-18"},{"key":"59294_CR43","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","volume":"177","author":"S Bangaru","year":"2019","unstructured":"Bangaru, S. et al. A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface. Cell 177, 1136\u20131152.e1118 (2019).","journal-title":"Cell"},{"key":"59294_CR44","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/9299","volume":"6","author":"D Fleury","year":"1999","unstructured":"Fleury, D. et al. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat. Struct. Biol. 6, 530\u2013534 (1999).","journal-title":"Nat. Struct. Biol."},{"key":"59294_CR45","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1128\/JVI.00420-14","volume":"88","author":"Y Iba","year":"2014","unstructured":"Iba, Y. et al. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses. J. Virol. 88, 7130\u20137144 (2014).","journal-title":"J. Virol."},{"key":"59294_CR46","doi-asserted-by":"publisher","unstructured":"Hale, M. et al. IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2. J. Exp. Med. 219, https:\/\/doi.org\/10.1084\/jem.20220849 (2022).","DOI":"10.1084\/jem.20220849"},{"key":"59294_CR47","doi-asserted-by":"publisher","first-page":"12471","DOI":"10.1128\/JVI.01388-13","volume":"87","author":"M Hong","year":"2013","unstructured":"Hong, M. et al. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. J. Virol. 87, 12471\u201312480 (2013).","journal-title":"J. Virol."},{"key":"59294_CR48","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","volume":"489","author":"DC Ekiert","year":"2012","unstructured":"Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526\u2013532 (2012).","journal-title":"Nature"},{"key":"59294_CR49","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1073\/pnas.1212371109","volume":"109","author":"PS Lee","year":"2012","unstructured":"Lee, P. S. et al. Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity. Proc. Natl. Acad. Sci. USA 109, 17040\u201317045 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59294_CR50","doi-asserted-by":"publisher","first-page":"e3002415","DOI":"10.1371\/journal.pbio.3002415","volume":"21","author":"HC Simmons","year":"2023","unstructured":"Simmons, H. C. et al. A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses. PLoS Biol. 21, e3002415 (2023).","journal-title":"PLoS Biol."},{"key":"59294_CR51","doi-asserted-by":"publisher","first-page":"e1007427","DOI":"10.1371\/journal.ppat.1007427","volume":"15","author":"S Saito","year":"2019","unstructured":"Saito, S. et al. IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody. PLoS Pathog. 15, e1007427 (2019).","journal-title":"PLoS Pathog."},{"key":"59294_CR52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.7150\/thno.28434","volume":"9","author":"C Shen","year":"2019","unstructured":"Shen, C. et al. An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency. Theranostics 9, 210\u2013231 (2019).","journal-title":"Theranostics"},{"key":"59294_CR53","doi-asserted-by":"publisher","first-page":"e0131531","DOI":"10.1371\/journal.pone.0131531","volume":"10","author":"CP Verschoor","year":"2015","unstructured":"Verschoor, C. P. et al. Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children. PLoS ONE 10, e0131531 (2015).","journal-title":"PLoS ONE"},{"key":"59294_CR54","doi-asserted-by":"publisher","first-page":"8607","DOI":"10.1128\/JVI.00159-10","volume":"84","author":"NA Ilyushina","year":"2010","unstructured":"Ilyushina, N. A. et al. Adaptation of pandemic H1N1 influenza viruses in mice. J. Virol. 84, 8607\u20138616 (2010).","journal-title":"J. Virol."},{"key":"59294_CR55","doi-asserted-by":"publisher","first-page":"e0227516","DOI":"10.1371\/journal.pone.0227516","volume":"15","author":"E-J Choi","year":"2020","unstructured":"Choi, E.-J. et al. The effect of mutations derived from mouse-adapted H3N2 seasonal influenza A virus to pathogenicity and host adaptation. PLoS ONE 15, e0227516 (2020).","journal-title":"PLoS ONE"},{"key":"59294_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.chom.2019.01.002","volume":"25","author":"C Henry","year":"2019","unstructured":"Henry, C. et al. Influenza virus vaccination elicits poorly adapted B cell responses in elderly individuals. Cell Host Microbe 25, 357\u2013366.e356 (2019).","journal-title":"Cell Host Microbe"},{"key":"59294_CR57","doi-asserted-by":"publisher","first-page":"e1010481","DOI":"10.1371\/journal.ppat.1010481","volume":"18","author":"P Koszalka","year":"2022","unstructured":"Koszalka, P., Subbarao, K. & Baz, M. Preclinical and clinical developments for combination treatment of influenza. PLoS Pathog. 18, e1010481 (2022).","journal-title":"PLoS Pathog."},{"key":"59294_CR58","doi-asserted-by":"publisher","unstructured":"Lim, J. J. et al. A phase 2 randomized,https:\/\/doi.org\/10.1093\/ofid\/ofab630 double-blind, placebo-controlled trial of MHAA4549A, a monoclonal antibody, plus oseltamivir in patients hospitalized with severe influenza A virus infection. Antimicrob. Agents Chemother. 64, https:\/\/doi.org\/10.1128\/aac.00352-20 (2020).","DOI":"10.1093\/ofid\/ofab630 10.1128\/aac.00352-20"},{"key":"59294_CR59","doi-asserted-by":"publisher","unstructured":"Vanderven, H. A. et al. Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza. JCI Insight 8, https:\/\/doi.org\/10.1172\/jci.insight.167464 (2023).","DOI":"10.1172\/jci.insight.167464"},{"key":"59294_CR60","doi-asserted-by":"publisher","unstructured":"Lim, J. J. et al. A phase 2 randomized, double-blind, placebo-controlled trial of the monoclonal antibody MHAA4549A in patients with acute uncomplicated influenza A infection. Open Forum Infect. Dis. 9, https:\/\/doi.org\/10.1093\/ofid\/ofab630 (2021).","DOI":"10.1093\/ofid\/ofab630"},{"key":"59294_CR61","doi-asserted-by":"publisher","unstructured":"Ali, S. O. et al. Evaluation of MEDI8852, an anti-influenza a monoclonal antibody, in treating acute uncomplicated influenza. Antimicrob. Agents Chemother. 62, https:\/\/doi.org\/10.1128\/AAC.00694-18 (2018).","DOI":"10.1128\/AAC.00694-18"},{"key":"59294_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8708","volume":"6","author":"Y Wu","year":"2015","unstructured":"Wu, Y. et al. A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus. Nat. Commun. 6, 7708 (2015).","journal-title":"Nat. Commun."},{"key":"59294_CR63","doi-asserted-by":"publisher","unstructured":"He, Y., Guo, Z., Subiaur, S., Benegal, A. & Vahey, M. D. Antibody inhibition of influenza A virus assembly and release. J. Virol. e0139823 https:\/\/doi.org\/10.1128\/jvi.01398-23 (2024).","DOI":"10.1128\/jvi.01398-23"},{"key":"59294_CR64","doi-asserted-by":"publisher","unstructured":"Williams, J. A., Gui, L., Hom, N., Mileant, A. & Lee, K. K. Dissection of epitope-specific mechanisms of neutralization of influenza virus by intact IgG and Fab fragments. J. Virol. 92, https:\/\/doi.org\/10.1128\/JVI.02006-17 (2018).","DOI":"10.1128\/JVI.02006-17"},{"key":"59294_CR65","doi-asserted-by":"publisher","unstructured":"Vigil, A., Frias-Staheli, N., Carabeo, T. & Wittekind, M. Airway delivery of anti-influenza monoclonal antibodies results in enhanced antiviral activities and enables broad-coverage combination therapies. J. Virol. 94, https:\/\/doi.org\/10.1128\/JVI.00052-20 (2020).","DOI":"10.1128\/JVI.00052-20"},{"key":"59294_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4939-8678-1_4","volume":"1836","author":"U Karakus","year":"2018","unstructured":"Karakus, U., Crameri, M., Lanz, C. & Yanguez, E. Propagation and titration of influenza viruses. Methods Mol. Biol. 1836, 59\u201388 (2018).","journal-title":"Methods Mol. Biol."},{"key":"59294_CR67","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/nar\/gkh340","volume":"32","author":"RC Edgar","year":"2004","unstructured":"Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792\u20131797 (2004).","journal-title":"Nucleic Acids Res."},{"key":"59294_CR68","doi-asserted-by":"publisher","first-page":"10905","DOI":"10.1128\/JVI.00700-11","volume":"85","author":"JC Krause","year":"2011","unstructured":"Krause, J. C. et al. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J. Virol. 85, 10905\u201310908 (2011).","journal-title":"J. Virol."},{"key":"59294_CR69","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.cell.2015.04.028","volume":"161","author":"AaronG Schmidt","year":"2015","unstructured":"Schmidt, AaronG. et al. Viral receptor-binding site antibodies with diverse germline origins. Cell 161, 1026\u20131034 (2015).","journal-title":"Cell"},{"key":"59294_CR70","doi-asserted-by":"publisher","first-page":"14216","DOI":"10.1073\/pnas.1111497108","volume":"108","author":"JRR Whittle","year":"2011","unstructured":"Whittle, J. R. R. et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 108, 14216\u201314221 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59294_CR71","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/prot.24745","volume":"83","author":"H Xu","year":"2015","unstructured":"Xu, H. et al. Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage. Proteins 83, 771\u2013780 (2015).","journal-title":"Proteins"},{"key":"59294_CR72","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1073\/pnas.1218256109","volume":"110","author":"AG Schmidt","year":"2013","unstructured":"Schmidt, A. G. et al. Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc. Natl. Acad. Sci. USA 110, 264\u2013269 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59294_CR73","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1073\/pnas.1715471115","volume":"115","author":"DD Raymond","year":"2018","unstructured":"Raymond, D. D. et al. Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody. Proc. Natl. Acad. Sci. USA 115, 168\u2013173 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"59294_CR74","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/prot.340230113","volume":"23","author":"B Gigant","year":"1995","unstructured":"Gigant, B., Fleury, D., Bizebard, T., Skehel, J. J. & Knossow, M. Crystallization and preliminary X-ray diffraction studies of complexes between an influenza hemagglutinin and Fab fragments of two different monoclonal antibodies. Proteins 23, 115\u2013117 (1995).","journal-title":"Proteins"},{"key":"59294_CR75","doi-asserted-by":"publisher","unstructured":"Qiu, Y. et al. Mapping of a novel H3-specific broadly neutralizing monoclonal antibody targeting the hemagglutinin globular head isolated from an elite influenza virus-immunized donor exhibiting serological breadth. J. Virol. 94, https:\/\/doi.org\/10.1128\/jvi.01035-19 (2020).","DOI":"10.1128\/jvi.01035-19"},{"key":"59294_CR76","doi-asserted-by":"publisher","first-page":"e1000350","DOI":"10.1371\/journal.ppat.1000350","volume":"5","author":"R Yoshida","year":"2009","unstructured":"Yoshida, R. et al. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLOS Pathog. 5, e1000350 (2009).","journal-title":"PLOS Pathog."},{"key":"59294_CR77","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.immuni.2017.12.009","volume":"48","author":"KR McCarthy","year":"2018","unstructured":"McCarthy, K. R. et al. Memory B cells that cross-react with group 1 and Group 2 influenza A viruses are abundant in adult human repertoires. Immunity 48, 174\u2013184.e179 (2018).","journal-title":"Immunity"},{"key":"59294_CR78","doi-asserted-by":"publisher","first-page":"11048","DOI":"10.1128\/JVI.05397-11","volume":"85","author":"N Ohshima","year":"2011","unstructured":"Ohshima, N. et al. Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5. J. Virol. 85, 11048\u201311057 (2011).","journal-title":"J. Virol."},{"key":"59294_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4614","volume":"5","author":"PS Lee","year":"2014","unstructured":"Lee, P. S. et al. Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat. Commun. 5, 3614 (2014).","journal-title":"Nat. Commun."},{"key":"59294_CR80","doi-asserted-by":"publisher","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","volume":"3","author":"M Throsby","year":"2008","unstructured":"Throsby, M. et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B Cells. PLoS ONE 3, e3942 (2008).","journal-title":"PLoS ONE"},{"key":"59294_CR81","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","volume":"324","author":"DC Ekiert","year":"2009","unstructured":"Ekiert, D. C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246\u2013251 (2009).","journal-title":"Science"},{"key":"59294_CR82","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","volume":"333","author":"DC Ekiert","year":"2011","unstructured":"Ekiert, D. C. et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843\u2013850 (2011).","journal-title":"Science"},{"key":"59294_CR83","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A Hemagglutinins. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"59294_CR84","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","volume":"166","author":"NL Kallewaard","year":"2016","unstructured":"Kallewaard, N. L. et al. Structure and function analysis of an antibody recognizing all influenza A subtypes. Cell 166, 596\u2013608 (2016).","journal-title":"Cell"},{"key":"59294_CR85","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"59294_CR86","doi-asserted-by":"publisher","unstructured":"Keyt, B. A., Baliga, R., Sinclair, A. M., Carroll, S. F. & Peterson, M. S. Structure, function, and therapeutic use of IgM antibodies. Antibodies 9, https:\/\/doi.org\/10.3390\/antib9040053 (2020).","DOI":"10.3390\/antib9040053"},{"key":"59294_CR87","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2010.05.003","volume":"359","author":"K Vorauer-Uhl","year":"2010","unstructured":"Vorauer-Uhl, K., Wallner, J., Lhota, G., Katinger, H. & Kunert, R. IgM characterization directly performed in crude culture supernatants by a new simple electrophoretic method. J. Immunol. Methods 359, 21\u201327 (2010).","journal-title":"J. Immunol. Methods"},{"key":"59294_CR88","unstructured":"World Health Organization. Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza (World Health Organization, 2011)."},{"key":"59294_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25713-1","volume":"12","author":"F Broszeit","year":"2021","unstructured":"Broszeit, F. et al. Glycan remodeled erythrocytes facilitate antigenic characterization of recent A\/H3N2 influenza viruses. Nat. Commun. 12, 5449 (2021).","journal-title":"Nat. Commun."},{"key":"59294_CR90","doi-asserted-by":"publisher","first-page":"e567","DOI":"10.1002\/cpz1.567","volume":"2","author":"F Cuevas","year":"2022","unstructured":"Cuevas, F., Kawabata, H., Krammer, F. & Carreno, J. M. Correction: an in vitro microneutralization assay for influenza virus serology. Curr. Protoc. 2, e567 (2022).","journal-title":"Curr. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59294-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59294-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59294-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T17:06:13Z","timestamp":1745946373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59294-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59294"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59294-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.G., C.C., S.H., J.W.S., W.R.S., and T.M. are\/were employees of IGM Biosciences. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4025"}}